109 related articles for article (PubMed ID: 8054866)
1. A rat model of thyroid hormone-induced bone loss: effect of antiresorptive agents on regional bone density and osteocalcin gene expression.
Kung AW; Ng F
Thyroid; 1994; 4(1):93-8. PubMed ID: 8054866
[TBL] [Abstract][Full Text] [Related]
2. Etidronate inhibits the thyroid hormone-induced bone loss in rats assessed by bone mineral density and messenger ribonucleic acid markers of osteoblast and osteoclast function.
Ongphiphadhanakul B; Jenis LG; Braverman LE; Alex S; Stein GS; Lian JB; Baran DT
Endocrinology; 1993 Dec; 133(6):2502-7. PubMed ID: 8243271
[TBL] [Abstract][Full Text] [Related]
3. Excessive L-thyroxine therapy decreases femoral bone mineral densities in the male rat: effect of hypogonadism and calcitonin.
Ongphiphadhanakul B; Alex S; Braverman LE; Baran DT
J Bone Miner Res; 1992 Oct; 7(10):1227-31. PubMed ID: 1456090
[TBL] [Abstract][Full Text] [Related]
4. Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin.
Kung AW; Yeung SS
J Clin Endocrinol Metab; 1996 Mar; 81(3):1232-6. PubMed ID: 8772604
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of bone loss in pre- and post-menopausal women on L-thyroxine therapy for non-toxic goitre.
De Rosa G; Testa A; Giacomini D; Carrozza C; Astazi P; Caradonna P
Clin Endocrinol (Oxf); 1997 Nov; 47(5):529-35. PubMed ID: 9425392
[TBL] [Abstract][Full Text] [Related]
6. Increased rat femur osteocalcin mRNA concentrations following in vivo administration of thyroid hormone.
Ross DS; Graichen R
J Endocrinol Invest; 1991 Oct; 14(9):763-6. PubMed ID: 1761812
[TBL] [Abstract][Full Text] [Related]
7. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
[TBL] [Abstract][Full Text] [Related]
8. Effect of TSH-suppressive doses of levothyroxine on bone mineral density in Thai women.
Ongphiphadhanakul B; Puavilai G; Rajatanavin R
J Med Assoc Thai; 1996 Sep; 79(9):563-7. PubMed ID: 8996984
[TBL] [Abstract][Full Text] [Related]
9. Site selectivity of osteoblast gene expression response to thyroid hormone localized by in situ hybridization.
Suwanwalaikorn S; Van Auken M; Kang MI; Alex S; Braverman LE; Baran DT
Am J Physiol; 1997 Feb; 272(2 Pt 1):E212-7. PubMed ID: 9124325
[TBL] [Abstract][Full Text] [Related]
10. Rapid inhibition of thyroxine-induced bone resorption in the rat by an orally active vitronectin receptor antagonist.
Hoffman SJ; Vasko-Moser J; Miller WH; Lark MW; Gowen M; Stroup G
J Pharmacol Exp Ther; 2002 Jul; 302(1):205-11. PubMed ID: 12065718
[TBL] [Abstract][Full Text] [Related]
11. Differential responses of femoral and vertebral bones to long-term excessive L-thyroxine administration in adult rats.
Suwanwalaikorn S; Ongphiphadhanakul B; Braverman LE; Baran DT
Eur J Endocrinol; 1996 May; 134(5):655-9. PubMed ID: 8664988
[TBL] [Abstract][Full Text] [Related]
12. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
Ma Y; Jee WS; Chen Y; Gasser J; Ke HZ; Li XJ; Kimmel DB
J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950
[TBL] [Abstract][Full Text] [Related]
13. Skeletal integrity in men chronically treated with suppressive doses of L-thyroxine.
Marcocci C; Golia F; Vignali E; Pinchera A
J Bone Miner Res; 1997 Jan; 12(1):72-7. PubMed ID: 9240728
[TBL] [Abstract][Full Text] [Related]
14. [Olpadronate prevents cortical and trabecular bone loss induced by supraphysiological dosis of thyroxine in ovariectomized rats].
Zeni SN; Gómez Acotto C; Di Gregorio S
Medicina (B Aires); 1998; 58(5 Pt 1):453-7. PubMed ID: 9922475
[TBL] [Abstract][Full Text] [Related]
15. Effects of cyclical etidronate with alfacalcidol on lumbar bone mineral density, bone resorption, and back pain in postmenopausal women with osteoporosis.
Iwamoto J; Takeda T; Ichimura S; Matsu K; Uzawa M
J Orthop Sci; 2003; 8(4):532-7. PubMed ID: 12898306
[TBL] [Abstract][Full Text] [Related]
16. Parenteral pamidronate prevents thyroid hormone-induced bone loss in rats.
Rosen HN; Sullivan EK; Middlebrooks VL; Zeind AJ; Gundberg C; Dresner-Pollak R; Maitland LA; Hock JM; Moses AC; Greenspan SL
J Bone Miner Res; 1993 Oct; 8(10):1255-61. PubMed ID: 8256663
[TBL] [Abstract][Full Text] [Related]
17. Effect of etidronate on bone in orchidectomized and sciatic neurectomized adult rats.
Iwamoto J; Takeda T; Katsumata T; Tanaka T; Ichimura S; Toyama Y
Bone; 2002 Feb; 30(2):360-7. PubMed ID: 11856643
[TBL] [Abstract][Full Text] [Related]
18. Thyroxine suppressive therapy decreases bone mineral density in post-menopausal women.
Kung AW; Lorentz T; Tam SC
Clin Endocrinol (Oxf); 1993 Nov; 39(5):535-40. PubMed ID: 8252741
[TBL] [Abstract][Full Text] [Related]
19. Supplementation of L-arginine prevents glucocorticoid-induced reduction of bone growth and bone turnover abnormalities in a growing rat model.
Pennisi P; D'Alcamo MA; Leonetti C; Clementi A; Cutuli VM; Riccobene S; Parisi N; Fiore CE
J Bone Miner Metab; 2005; 23(2):134-9. PubMed ID: 15750691
[TBL] [Abstract][Full Text] [Related]
20. Effects of thyroid hormone administration and estrogen deficiency on bone mass of female rats.
Gouveia CH; Jorgetti V; Bianco AC
J Bone Miner Res; 1997 Dec; 12(12):2098-107. PubMed ID: 9421243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
